Annual Shareholders Equity
$495.68 M
+$446.78 M+913.69%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual stockholders equity is $495.68 million, with the most recent change of +$446.78 million (+913.69%) on December 31, 2023.
- During the last 3 years, MLTX annual shareholders equity has risen by +$507.32 million (+4356.55%).
- MLTX annual shareholders equity is now at all-time high.
Performance
MLTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$488.20 M
-$32.47 M-6.24%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly stockholders equity is $488.20 million, with the most recent change of -$32.47 million (-6.24%) on September 30, 2024.
- Over the past year, MLTX quarterly shareholders equity has dropped by -$32.47 million (-6.24%).
- MLTX quarterly shareholders equity is now -10.02% below its all-time high of $542.55 million, reached on March 31, 2024.
Performance
MLTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MLTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +913.7% | -6.2% |
| 3 y3 years | +4356.6% | +4292.3% |
| 5 y5 years | +4356.6% | +4292.3% |
MLTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4356.6% | -10.0% | +4292.3% |
| 5 y | 5-year | at high | +4356.6% | -10.0% | +4292.3% |
| alltime | all time | at high | +4356.6% | -10.0% | +4292.3% |
MoonLake Immunotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $488.20 M(-6.2%) |
| Jun 2024 | - | $520.66 M(-4.0%) |
| Mar 2024 | - | $542.55 M(+9.5%) |
| Dec 2023 | $495.68 M | $495.68 M(+16.6%) |
| Sep 2023 | - | $424.93 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $489.80 M(+1066.2%) |
| Mar 2023 | - | $42.00 M(-14.1%) |
| Dec 2022 | $48.90 M(-519.9%) | $48.90 M(-11.6%) |
| Sep 2022 | - | $55.29 M(-13.0%) |
| Jun 2022 | - | $63.51 M(-645.4%) |
| Dec 2021 | -$11.64 M | -$11.64 M |
FAQ
- What is MoonLake Immunotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
- What is MoonLake Immunotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?
What is MoonLake Immunotherapeutics annual stockholders equity?
The current annual shareholders equity of MLTX is $495.68 M
What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual stockholders equity is $495.68 M
What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
Over the past year, MLTX annual stockholders equity has changed by +$446.78 M (+913.69%)
What is MoonLake Immunotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MLTX is $488.20 M
What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly stockholders equity is $542.55 M
What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, MLTX quarterly stockholders equity has changed by -$32.47 M (-6.24%)